Preferential macrophage recruitment and polarization in LPS-induced animal model for COPD: Noninvasive tracking using MRI

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Al Faraj, Achraf ^a   Sultana Shaik, Asma ^a   Pureza, Mary Angeline ^b   Alnafea, Mohammad ^a   Halwani, Rabih ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE MODIFIED PEGYLATED DEXTRAN COATED SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LABELING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; POLARIZATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL DEATH; CELL POLARITY; CELL SURVIVAL; CELL TRACKING; CHEMOKINES; DEXTRANS; DISEASE MODELS, ANIMAL; FEMALE; FERRIC COMPOUNDS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; NANOPARTICLES; POLYETHYLENE GLYCOLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES; STAINING AND LABELING; STATIC ELECTRICITY;

EID: 84897139416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090829     Document Type: Article

References (42)

1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Obstructive Lung Disease. Available: http://www.goldcopd.com. Accessed 2013 Feb 20: GOLD 2013.
2. Barnes P (2004) Alveolar Macrophages as Orchestrators of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 1: 59-70.
3. Herold S, Mayer K, Lohmeyer J (2011) Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol 2: 65.
4. Biswas SK, Chittezhath M, Shalova IN, Lim JY (2012) Macrophage polarization and plasticity in health and disease. Immunol Res 53: 11-24.
5. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
6. Boorsma CE, Draijer C, Melgert BN (2013) Macrophage heterogeneity in respiratory diseases. Mediators Inflamm 2013: 769214.
7. Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, et al. (2012) Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine (Lond) 7: 1253-1271.
8. Lee JS, Kang HJ, Gong G, Jung HD, Lim KH, et al. (2006) MR imaging of in vivo recruitment of iron oxide-labeled macrophages in experimentally induced soft-tissue infection in mice. Radiology 241: 142-148. (Pubitemid 44433344)
9. Hauger O, Grenier N, Deminere C, Lasseur C, Delmas Y, et al. (2007) USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans. Eur Radiol 17: 2898-2907. (Pubitemid 47603986)
10. Cai QY, Lee H, Kim EJ, Moon H, Chang K, et al. (2012) Magnetic resonance imaging of superparamagnetic iron oxide-labeled macrophage infiltrates in acute-phase renal ischemia-reperfusion mouse model. Nanomedicine 8: 365-373.
11. Soenen SJ, De Cuyper M (2010) Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine (Lond) 5: 1261-1275.
12. Singh N, Jenkins GJ, Asadi R, Doak SH (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1.
13. Wang YX (2011) Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 1: 35-40.
14. Tyler DJ, Robson MD, Henkelman RM, Young IR, Bydder GM (2007) Magnetic resonance imaging with ultrashort TE (UTE) PULSE sequences: technical considerations. J Magn Reson Imaging 25: 279-289. (Pubitemid 46204578)
15. Ebner B, Behm P, Jacoby C, Burghoff S, French BA, et al. (2010) Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging 3: 202-210.
16. Strobel K, Hoerr V, Schmid F, Wachsmuth L, Loffler B, et al. (2012) Early detection of lung inflammation: exploiting T1-effects of iron oxide particles using UTE MRI. Magn Reson Med 68: 1924-1931.
17. Al Faraj A, Luciani N, Kolosnjaj-Tabi J, Mattar E, Clement O, et al. (2013) Real-time high-resolution magnetic resonance tracking of macrophage subpopulations in a murine inflammation model: a pilot study with a commercially available cryogenic probe. Contrast Media Mol Imaging 8: 193-203.
18. Tang KS, Shapiro EM (2011) Enhanced magnetic cell labeling efficiency using - NH2 coated MPIOs. Magn Reson Med 65: 1564-1569.
19. Zhu XM, Wang YX, Leung KC, Lee SF, Zhao F, et al. (2012) Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines. Int J Nanomedicine 7: 953-964.
20. Al Faraj A (2013) Preferential magnetic nanoparticle uptake by bone marrow derived macrophages sub-populations: effect of surface coating on polarization, toxicity, and in vivo MRI detection. Journal of Nanoparticle Research 15: 1-13.
21. Chen Z, Xu R, Zhang Y, Gu N (2008) Effects of proteins from culture medium on surface property of silanes- functionalized magnetic nanoparticles. Nanoscale Res Lett 4: 204-209.
22. Cecilio CA, Costa EH, Simioni PU, Gabriel DL, Tamashiro WM (2011) Aging alters the production of iNOS, arginase and cytokines in murine macrophages. Braz J Med Biol Res 44: 671-681.
23. Vazquez-Tello A, Halwani R, Li R, Nadigel J, Bar-Or A, et al. (2012) IL-17A and IL-17F expression in B lymphocytes. Int Arch Allergy Immunol 157: 406-416.
24. Saito S, Tsugeno M, Koto D, Mori Y, Yoshioka Y, et al. (2012) Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages. Int J Nanomedicine 7: 5415-5421.
25. Yu SS, Lau CM, Thomas SN, Jerome WG, Maron DJ, et al. (2012) Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages. Int J Nanomedicine 7: 799-813.
26. Oude Engberink RD, van der Pol SM, Dopp EA, de Vries HE, Blezer EL (2007) Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 243: 467-474. (Pubitemid 46649703)
27. Schweiger C, Hartmann R, Zhang F, Parak WJ, Kissel TH, et al. (2012) Quantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite charge. J Nanobiotechnology 10: 28.
28. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40: 715-724. (Pubitemid 41546838)
29. Lum H, Roebuck KA (2001) Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280: C719-741.
30. Soenen SJ, De Cuyper M, De Smedt SC, Braeckmans K (2012) Investigating the toxic effects of iron oxide nanoparticles. Methods Enzymol 509: 195-224.
31. Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, et al. (2009) M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J Immunol 182: 4415-4422.
32. Matute-Bello G, Frevert CW, Martin TR (2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L379-399.
33. Wouters EF, Reynaert NL, Dentener MA, Vernooy JH (2009) Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc 6: 638-647.
34. Galli SJ, Borregaard N, Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12: 1035-1044.
35. Zheng XF, Hong YX, Feng GJ, Zhang GF, Rogers H, et al. (2013) Lipopolysaccharide-induced M2 to M1 macrophage transformation for IL-12p70 production is blocked by Candida albicans mediated up-regulation of EBI3 expression. PLoS One 8: e63967.
36. Yamashita U, Kuroda E (2002) Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol 22: 105-114. (Pubitemid 35244753)
37. Ying S, O'Connor B, Ratoff J, Meng Q, Fang C, et al. (2008) Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 181: 2790-2798.
38. Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, et al. (1997) Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185: 1595-1604. (Pubitemid 27203256)
39. Frankenberger M, Eder C, Hofer TP, Heimbeck I, Skokann K, et al. (2011) Chemokine expression by small sputum macrophages in COPD. Mol Med 17: 762-770.
40. Vulcano M, Albanesi C, Stoppacciaro A, Bagnati R, D'Amico G, et al. (2001) Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 31: 812-822. (Pubitemid 32241777)
41. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, et al. (2010) Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol 176: 774-785.
42. Redente EF, Higgins DM, Dwyer-Nield LD, Orme IM, Gonzalez-Juarrero M, et al. (2010) Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol 88: 159-168.